Objective To compare the efficacy of insulin aspart and human soluble insulin used in insulin pump therapy on the islets β cell function in newly diagnosed type 2 diabetic patients.

1、

Objective To compare the efficacy and safety of premixed insulin aspart with human insulin premix used in a twice-daily injection in the patients with type 2 diabetes.

目的探讨每日2次注射预混门冬胰岛素30（诺和锐30特充）和预混人胰岛素30R（诺和灵30R）治疗口服降糖药效果不佳的2型糖尿病的疗效及低血糖风险。

互联网摘选

2、

Conclusion Insulin aspart 30/ 70 is better than the biphasic human insulin 30/ 70 in lowering postprandial blood glucose and HbA1c.

结论预混门冬氨酸胰岛素30/70降餐后血糖和HbA1C明显优于精蛋白生物合成人胰岛素30/70。

互联网摘选

3、

Comparison between the effects of insulin Aspart and Novolin R via continuous subcutaneous insulin infusion pump on hyperglycemia in elderly patients with type 2 diabetes

门冬胰岛素与人普通胰岛素在老年2型糖尿病胰岛素泵治疗中的疗效比较

互联网摘选

4、

Effect of insulin glargine plus insulin aspart or insulin pumps on β-cell function of patients with the newly diagnosed type 2 diabetes mellitus

甘精胰岛素联合门冬胰岛素与胰岛素泵对新患2型糖尿病胰岛细胞功能影响的比较

互联网摘选

5、

Objective To investigate the efficacy and safety of insulin aspart 30/ 70 in the treatment of type 2 diabetes mellitus ( T2DM).

目的观察预混门冬氨酸胰岛素30/70（降血糖药）对2型糖尿病的疗效与安全性。

互联网摘选

6、

Comparison of therapeutic effects between insulin glargine combined with glimepiride and insulin aspart 30 in treating type 2 diabetes mellitus

甘精胰岛素联合格列美脲与诺和锐30治疗2型糖尿病的疗效比较

互联网摘选

7、

Conclusion Short-term intensive therapy with NovoPen and aspart can rapidly and stably control glucose and significantly improve β-cell function.

结论用诺和笔加诺和锐短期强化治疗可以快速稳定控制血糖并显著改善胰岛β细胞功能。

互联网摘选

8、

A comparison of premixed insulin aspart 30 and premixed human insulin 30R in treatment of type 2 diabetes

预混门冬胰岛素30和预混人胰岛素30R治疗2型糖尿病的对比研究

互联网摘选

9、

Efficacy and safety of insulin aspart used in continuous subcutaneous insulin infusion therapy in children and adolescences with type 1 diabetes

门冬胰岛素在青少年1型糖尿病胰岛素泵中的应用

互联网摘选

10、

Clinical study of intensification treatment by using aspart in insulin pump to control hyperglycemia in T_2DM patient in a short period

胰岛素泵输注诺和锐短期强化治疗2型糖尿病的临床疗效观察

互联网摘选

11、

A comparison between insulin aspart and human regular insulin via continuous subcutaneous insulin infusion pump in patients with type 2 diabetes

用诺和锐和诺和灵R持续皮下输注治疗2型糖尿病的疗效对比

互联网摘选

12、

Effects of combination of insulin Aspart 30 and pioglitazone hydrochloride on blood glucose in type 2 diabetes mellitus patients

门冬胰岛素30与盐酸吡格列酮联合治疗对2型糖尿病患者血糖的影响

互联网摘选

13、

Conclusion Insulin aspart 30 intensive treatment can effectively improve plasma glucose and pancreatic function in newly diagnosed type 2 diabetes.

结论诺和锐30强化治疗能显著改善初诊2型糖尿病患者的血糖及胰岛功能。

互联网摘选

14、

Effects of insulin aspart 30 and acarbose on β-cell function in newly diagnosed type 2 diabetes

门冬胰岛素30联合阿卡波糖对初诊2型糖尿病胰岛功能的影响

互联网摘选

15、

Continuous subcutaneous injection of human insulin analog ( Insulin Aspart) treats type 2 diabetes mellitus

人胰岛素类似物（Insulin Aspart）持续皮下注射治疗2型糖尿病

互联网摘选

16、

Clinical Observation on Postprandial Injection of Insulin Aspart Injection in Patients with type 2 Diabetes and Cerebral Infarction

门冬胰岛素餐后注射对2型糖尿病合并脑梗死患者的临床观察

互联网摘选

17、

Perioperative hyperglycemia control with insulin aspart injection used in insulin pump in patients with type 2 diabetes mellitus

2型糖尿病病人围手术期应用胰岛素泵输注诺和锐控制高血糖的临床研究

互联网摘选

18、

Effective observation of insulin aspart and regular insulin on children with type ⅰ diabetes mellitus

应用诺和锐和诺和灵R治疗儿童Ⅰ型糖尿病的疗效观察

互联网摘选

19、

Comparison of therapeutic efficacy between Aspart and regular human insulin delivered by insulin pump

Aspart与正规人胰岛素应用胰岛素泵控制血糖的疗效比较

互联网摘选

20、

Clinical Investigation on Insulin Aspart 30 in Firstly Diagnosed Severe Type 2 Mellitus Patients

初诊重度2-型糖尿病（T2DM）应用门冬胰岛素30疗效观察

互联网摘选